Brain Fistula Study
Protocol: SITE00000177
Full Title
PHIL DAVF: PHIL Embolic System in the Treatment of Dural Arteriovenous Fistulas.
Description
This study enrolls people with brain artery/vein abnormalities. The purpose of this study is to collect information about how the a device called the PHIL® Embolic System works to treat this issue, called intracranial dural arteriovenous fistulas. The device contains a liquid that is meant to reduce blood flow to the area that needs treatment.

You will be involved in this study for about 6 months. Study takes place at Gates Vascular Institute, 875 Ellicott St, Buffalo NY 14203.

Compensation is not available.

Technical Description

To evaluate the safety and probable benefit of MicroVention, Inc. PHIL?? Liquid Embolic material for the treatment of intracranial dural arteriovenous fistulas.
Compensation: No
Eligibility
Adults ages 22-80.
Have been diagnosed with a dural arteriovenous fistula (DAVF).
Age Group: Adults
Principal Investigator: ADNAN SIDDIQUI
ClinicalTrials.gov: Open Study
Contact(s)
JENNIFER GAY
jgay@ubns.com
+1 716-888-4811
Want to Learn More?
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.